Cargando…
Pneumocystis jirovecii pneumonia: a proposed novel model of corticosteroid benefit
Autores principales: | Gharamti, Amal A., Mundo, William, Chastain, Daniel B., Franco-Paredes, Carlos, Henao-Martínez, Andrés F., Shapiro, Leland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295936/ https://www.ncbi.nlm.nih.gov/pubmed/34349985 http://dx.doi.org/10.1177/20499361211032034 |
Ejemplares similares
-
1171. Lower Mortality with Adjuvant Corticosteroid Therapy in non-HIV Infected Patients with pneumocystis jirovecii pneumonia: A Single US Cohort Study and a Proposed Novel Mechanism of Corticosteroids
por: Mundo, William, et al.
Publicado: (2020) -
Lower Mortality Associated With Adjuvant Corticosteroid Therapy in Non-HIV-Infected Patients With Pneumocystis jirovecii Pneumonia: A Single-Institution Retrospective US Cohort Study
por: Mundo, William, et al.
Publicado: (2020) -
Pneumocystis jirovecii pneumonia following corticosteroid therapy
por: Garça, Magda, et al.
Publicado: (2023) -
Previous corticosteroid exposure associates with an increased Pneumocystis jirovecii pneumonia mortality among HIV-negative patients: a global research network with a follow-up multicenter case-control study
por: Vargas Barahona, Lilian, et al.
Publicado: (2023) -
Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?
por: Shapiro, Leland, et al.
Publicado: (2023)